On the reliability of mitotic count on biopsy samples of gastrointestinal stromal tumors.
Department of Pathology, Catholic University, Largo A. Gemelli, 8, I-00168 Rome, Italy. Electronic address: riccardoricci@rm.unicatt.it.
R
R
Ricci
Department of Pathology, Catholic University, Largo A. Gemelli, 8, I-00168 Rome, Italy.
G
G
Chiarello
Digestive Endoscopy Unit, Catholic University, Largo A. Gemelli, 8, I-00168 Rome, Italy.
G
G
Vanella
Digestive Endoscopy Unit, Catholic University, Largo A. Gemelli, 8, I-00168 Rome, Italy.
A
A
Larghi
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use*; D005770:Gastrointestinal Neoplasms / Q000145:classification* / Q000188:drug therapy*; D046152:Gastrointestinal Stromal Tumors / Q000145:classification* / Q000188:drug therapy*; D006801:Humans; D058990:Molecular Targeted Therapy; D010348:Patient Care Team; D018579:Patient Selection; D010879:Piperazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines
Biopsy; Fine-needle tissue acquisition; GIST; Prognosis; Risk assessment